Baird R W lowered shares of Tenet Healthcare (NYSE:THC - Free Report) from a strong-buy rating to a hold rating in a report issued on Tuesday morning,Zacks.com reports.
A number of other research firms also recently weighed in on THC. Guggenheim started coverage on Tenet Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $165.00 target price on the stock. JPMorgan Chase & Co. restated an "overweight" rating and set a $175.00 target price on shares of Tenet Healthcare in a research note on Tuesday, December 17th. The Goldman Sachs Group downgraded shares of Tenet Healthcare from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $196.00 to $140.00 in a research report on Monday, December 16th. Truist Financial decreased their price target on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, KeyCorp lowered their price target on Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and a consensus target price of $165.44.
View Our Latest Analysis on THC
Tenet Healthcare Trading Down 8.4 %
NYSE:THC traded down $10.28 during trading hours on Tuesday, reaching $111.53. The company's stock had a trading volume of 725,100 shares, compared to its average volume of 1,499,960. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare has a 1 year low of $92.01 and a 1 year high of $171.20. The firm has a market capitalization of $10.53 billion, a price-to-earnings ratio of 3.46, a PEG ratio of 1.02 and a beta of 1.77. The firm has a 50-day simple moving average of $127.88 and a 200-day simple moving average of $138.01.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. Research analysts expect that Tenet Healthcare will post 12.24 EPS for the current fiscal year.
Insider Buying and Selling at Tenet Healthcare
In related news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the sale, the director now directly owns 27,378 shares of the company's stock, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.93% of the company's stock.
Hedge Funds Weigh In On Tenet Healthcare
A number of large investors have recently added to or reduced their stakes in the stock. New Wave Wealth Advisors LLC purchased a new stake in shares of Tenet Healthcare during the 4th quarter valued at approximately $343,000. Swedbank AB increased its position in shares of Tenet Healthcare by 100.0% in the 4th quarter. Swedbank AB now owns 40,000 shares of the company's stock valued at $5,049,000 after purchasing an additional 20,000 shares during the last quarter. Signet Financial Management LLC acquired a new position in shares of Tenet Healthcare during the 4th quarter worth about $1,526,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Tenet Healthcare in the 4th quarter valued at about $5,892,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.
Tenet Healthcare Company Profile
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Recommended Stories

Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.